Small diameter melanoma: a follow-up of the Norwegian Melanoma Project

被引:28
|
作者
Helsing, P [1 ]
Loeb, M
机构
[1] Univ Oslo, Natl Hosp, Dept Dermatol, N-0027 Oslo, Norway
[2] SINTEF Unimed, N-0314 Oslo, Norway
关键词
melanoma; prognosis;
D O I
10.1111/j.1365-2133.2004.06248.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Melanoma prognosis is dependent upon early recognition and treatment. There is a need for good clinical guidelines that focus on the early signs of melanoma. The ABCD (asymmetry, border, colour and diameter) rule states that most melanomas are more than 6 mm in diameter. Critics crave a modification, arguing that small diameter melanomas are not infrequent. Objectives The aim of the present study was to describe the frequency and prognosis of melanomas less than 7 mm in a clinical setting. Methods The Norwegian Melanoma Project was conducted as a multicentre, prospective study with inclusion criteria. Patients were recruited from five dermatological departments in Norway from 1990 to 1993. Results The frequency of small melanomas was 11.4% (18/158). One-third was in situ melanoma, the rest invasive with a median thickness of 0.8 mm. Four small melanomas were T2 lesions, with a Breslow thickness of more than 1 mm. One nodular T2 melanoma recurred locally 2 years after diagnosis and the patient died of distant metastasis only months later. Conclusions The ABCD rule remains a practical guide for early recognition of melanoma. Clinicians must be aware of its limitations.
引用
收藏
页码:1081 / 1083
页数:3
相关论文
共 50 条
  • [21] Follow-up requirements for thick cutaneous melanoma
    Sylaidis, P
    Gordon, D
    Rigby, H
    Kenealy, J
    BRITISH JOURNAL OF PLASTIC SURGERY, 1997, 50 (05): : 349 - 353
  • [22] Intensity of Follow-Up After Melanoma Surgery
    Scally, Christopher P.
    Wong, Sandra L.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) : 752 - 757
  • [23] Intensity of Follow-Up After Melanoma Surgery
    Christopher P. Scally
    Sandra L. Wong
    Annals of Surgical Oncology, 2014, 21 : 752 - 757
  • [24] Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohort
    Robsahm, Trude E.
    Falk, Ragnhild S.
    Eide, Nils A.
    ACTA OPHTHALMOLOGICA, 2023, 101 (06) : 696 - 704
  • [25] Follow-up schedules after treatment for malignant melanoma
    Francken, A. B.
    Accortt, N. A.
    Shaw, H. M.
    Colman, M. H.
    Wiener, M.
    Soong, S. -J.
    Hoekstra, H. J.
    Thompson, J. F.
    BRITISH JOURNAL OF SURGERY, 2008, 95 (11) : 1401 - 1407
  • [26] Swiss guidelines for the treatment and follow-up of cutaneous melanoma
    Dummer, R
    Bösch, U
    Panizzon, R
    Bloch, PH
    Burg, G
    DERMATOLOGY, 2001, 203 (01) : 75 - 80
  • [27] Usefulness of paraclinical follow-up in stage I melanoma
    Bastien, M
    Tessier, MH
    Legoux, B
    Litoux, P
    Bureau, B
    Dreno, B
    ARCHIVES OF DERMATOLOGY, 1997, 133 (11) : 1462 - 1463
  • [28] Evidence-Based Follow-up for the Patient with Melanoma
    Fields, Ryan C.
    Coit, Daniel G.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 20 (01) : 181 - +
  • [29] Effectiveness of clinical and instrumental follow-up for cutaneous melanoma
    Toia, Francesca
    Cajozzo, Marta
    Rosatti, Fernando
    Di Lorenzo, Sara
    Rinaldi, Gaetana
    Mazzucco, Walter
    Cordova, Adriana
    SURGICAL ONCOLOGY-OXFORD, 2022, 44
  • [30] 6 Years Follow-Up Sinonasal Malignant Melanoma
    Pietrosanu, Catalina
    Zainea, Viorel
    Ionita, Irina Gabriela
    Plesca, Vlad Stefan
    Rusescu, Andreea
    Iana, Ruxandra Oana
    Stefanescu, Dragos Cristian
    Marinescu, Andreea
    Pantea Stoian, Anca
    Hainarosie, Razvan
    PROCEEDINGS OF NATIONAL ENT, HEAD AND NECK SURGERY CONFERENCE, 2018, : 416 - 421